Gene · 2285
Papers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 19F chemical library and 19F-NMR for a weakly bound complex structure. | RSC Med Chem | 2022 | 36324497 | PubTator, text mining | PubMed |
| The factors influencing the efficiency of drug-coated balloons. | Front Cardiovasc Med | 2022 | 36312265 | PubTator, text mining | PubMed |
| Merits of Diazirine Photo-Immobilization for Target Profiling of Natural Products and Cofactors. | ACS Chem Biol | 2022 | 36302507 | PubTator, text mining | PubMed |
| Kap-β2/Transportin mediates β-catenin nuclear transport in Wnt signaling. | Elife | 2022 | 36300792 | PubTator, text mining | PubMed |
| mTOR as a Potential Target for the Treatment of Microbial Infections, Inflammatory Bowel Diseases, and Colorectal Cancer. | Int J Mol Sci | 2022 | 36293326 | PubTator, text mining | PubMed |
| Applications of covalent chemistry in targeted protein degradation. | Chem Soc Rev | 2022 | 36285735 | PubTator, text mining | PubMed |
| In human astrocytes neurotropic flaviviruses increase autophagy, yet their replication is autophagy-independent. | Cell Mol Life Sci | 2022 | 36283999 | PubTator, text mining | PubMed |
| Intercellular transfer of activated STING triggered by RAB22A-mediated non-canonical autophagy promotes antitumor immunity. | Cell Res | 2022 | 36280710 | PubTator, text mining | PubMed |
| Targeting the ubiquitin system by fragment-based drug discovery. | Front Mol Biosci | 2022 | 36275626 | PubTator, text mining | PubMed |
| A cell-based chemical-genetic screen for amino acid stress response inhibitors reveals torins reverse stress kinase GCN2 signaling. | J Biol Chem | 2022 | 36273589 | PubTator, text mining | PubMed |
| Proteolysis Targeting Chimeras (PROTACs): A Perspective on Integral Membrane Protein Degradation. | ACS Pharmacol Transl Sci | 2022 | 36268122 | PubTator, text mining | PubMed |
| Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2. | J Clin Invest | 2022 | 36264642 | PubTator, text mining | PubMed |
| The E3 ligase adapter cereblon targets the C-terminal cyclic imide degron. | Nature | 2022 | 36261529 | PubTator, text mining | PubMed |
| Multiplex quadruple bioluminescent assay system. | Sci Rep | 2022 | 36261452 | PubTator, text mining | PubMed |
| Small molecule inhibitors targeting the cancers. | MedComm (2020) | 2022 | 36254250 | PubTator, text mining | PubMed |
| A phase II evaluation of temsirolimus with carboplatin and paclitaxel followed by temsirolimus consolidation in clear cell ovarian cancer: An NRG oncology trial. | Gynecol Oncol | 2022 | 36244829 | PubTator, text mining | PubMed |
| Discovery of E3 Ligase Ligands for Target Protein Degradation. | Molecules | 2022 | 36235052 | PubTator, text mining | PubMed |
| Small Molecules for Enhancing the Precision and Safety of Genome Editing. | Molecules | 2022 | 36234804 | PubTator, text mining | PubMed |
| Drosophila as a Model Organism to Study Basic Mechanisms of Longevity. | Int J Mol Sci | 2022 | 36232546 | PubTator, text mining | PubMed |
| MDM2-Based Proteolysis-Targeting Chimeras (PROTACs): An Innovative Drug Strategy for Cancer Treatment. | Int J Mol Sci | 2022 | 36232374 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2285/papers?page=17